globalbarry. Company Intelligence Engine

Lexeo Therapeutics, Inc.

LXEO CIK 0001907108 · Biological Products, (No Diagnostic Substances) (SIC 2836)

Disclosed SEC business address
345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010

Lexeo Therapeutics, Inc. (ticker LXEO, CIK 0001907108) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Biological Products, (No Diagnostic Substances) (SIC 2836). Disclosed business address country: United States. Every item is grounded on the cited public source — no figures are fabricated.

51 exposure relationships mapped 51 related entities (events · industries · countries) Intelligence last refreshed 2026-11-04

Top findings public preview

  • FACT Disclosed industry: Biological Products, (No Diagnostic Substances) (SIC 2836)
  • FACT Country of disclosed business address: United States
  • FACT SCHEDULE 13G filed 2026-10-13 source ↗

Go deeper

This is the free public preview. Open the deeper, source-linked evidence detail and the full in-app workspace. You have 0 free company deep views left this month.

Sources

Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.